Noah Moss

References 1. "The Society of Thoracic Surgeons Intermacs 2022 annual report: focus on the 2018 Heart Transplant Allocation System". Ann Thorac Surg . 2023;115:311-327. 2. "Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure". Circulation . 1998;98:2383-2389. 3. "Left ventricular assist device and drug therapy for the reversal of heart failure". N Engl J Med . 2006;355:1873-1884. 4.

Previous retrospective studies suggest a good diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)/computed tomography (CT) in left ventricular assist device (LVAD) infections. Our aim was to prospectively evaluate the role of PET/CT in the characterization and impact on clinical management of LVAD infections. A total of 40 patients (aged 58 [53-62] years) with suspected LVAD infection and 5 controls (aged 69 [64-71] years) underwent 18F-FDG-PET/CT.

Abstract Originally intended for life-saving salvage therapy, the use of temporary mechanical circulatory support (MCS) devices has become increasingly widespread in a variety of clinical settings in the contemporary era. Their use as a short-term, prophylactic support vehicle has expanded to include procedures in the catheterization laboratory, electrophysiology suite, operating room and intensive care unit. Accordingly, MCS device design and technology continue to develop at a rapid pace.